ScholarWorks@SUNGKYUNKWAN UNIVERSITY

Current filters:
Current filters:
Add filters:

Results 1,031-1,033 of 1,033 (Search time: 0.009 seconds).

SCIESCOPUS
Efficacy and safety of GX-188E, a therapeutic DNA vaccine, combined with pembrolizumab in HPV 16-and/or 18-positive advanced cervical cancer (phase II): Safe and effective in both PD-L1 positive and negative

Lee, S[Lee, S.]; Lim, MC[Lim, M-C.]; Kim, YM[Kim, Y. M.]; No, JH[No, J. H.]; Kim, BG[Kim, B-G.]; Cho, CH[Cho, C. H.]; Kim, SH[Kim, S. H.]; Jeong, DH[Jeong, D. H.]; Lee, JK[Lee, J-K.]; Park, JS[Park, J. S.], et al.

ArticleIssue Date2022CitationANNALS OF ONCOLOGY, v.33, no.7, pp.S1398 - S1398PublisherELSEVIER
SCIESCOPUS
The PROCEED trial KCSG BR11-01 phase III multicenter randomized open-label study of irinotecan plus capecitabine versus capecitabine in patients previously treated with anthracycline and taxane for HER2 negative metastatic breast cancer

Park, IH[Park, I. H.]; Im, SA[Im, S-A]; Jung, KH[Jung, K. H.]; Sohn, JH[Sohn, J. H.]; Park, YH[Park, Y. H.]; Park, KH[Park, K-H]; Nam, BH[Nam, B-H]; Kim, JH[Kim, J. H.]; Kim, HJ[Kim, H-J]; Lee, S[Lee, S.], et al.

ArticleIssue Date2017CitationCANCER RESEARCH, v.77PublisherAMER ASSOC CANCER RESEARCH
SCIESCOPUS
MRE-seq based cancer screening for lung and colorectal cancer by deep learning analysis of cfDNA methylation pattern cancer screening

Shin, SH[Shin, S. H.]; Kwon, HJ[Kwon, H-J.]; Kim, HH[Kim, H. H.]; Min, NY[Min, N. Y.]; Lim, Y[Lim, Y.]; Joo, T[Joo, T.]; Lee, KJ[Lee, K. J.]; Jeong, MS[Jeong, M-S.]; Kim, H[Kim, H.]; Um, SW[Um, S-W.], et al.

ArticleIssue Date2022CitationANNALS OF ONCOLOGY, v.33, no.7, pp.S553 - S553PublisherELSEVIER
1 101 102 103 104

Discover

Language

Journal Index

STATISTICS
Total View :5,512,583
Today View :590

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어